{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:53:23Z","timestamp":1761519203763},"reference-count":44,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2001,5,1]]},"abstract":"<jats:p> PURPOSE: Papilla of Vater cancer has a much better prognosis than pancreatic cancer. It is not known whether this is the result of differences in the tumor biology of the two malignancies. Because metastasis formation is a critical step in tumor progression and a negative prognostic factor, we compared the expression of nm23-H1 and KAI1, two metastasis-suppressing genes, in papilla of Vater cancer and pancreatic cancer. <\/jats:p><jats:p> PATIENTS AND METHODS: Analysis was performed in nine normal human papilla of Vater samples, 27 papilla of Vater cancers, 16 normal pancreatic samples, and 29 pancreatic cancers. Expression of nm23-H1 and KAI1 was analyzed by Northern blot analysis and in situ hybridization. In addition, immunohistochemistry was performed to localize the respective proteins. <\/jats:p><jats:p> RESULTS: There was no difference in nm23-H1 and KAI1 mRNA expression levels in normal versus cancerous papilla of Vater samples. In contrast, nm23-H1 and KAI1 RNA expression was upregulated in early tumor stages of pancreatic cancer and reduced in advanced tumor stages. When expression of nm23-H1 and KAI1 RNA was analyzed by use of in situ hybridization, normal epithelial cells of the papilla of Vater exhibited mRNA staining intensity similar to that of papilla of Vater cancer cells. Similar levels of nm23-H1 and KAI1 immunoreactivity also were observed in these samples. In contrast, early stage pancreatic cancer samples exhibited stronger nm23-H1 and KAI1 immunoreactivity than normal controls. Furthermore, early pancreatic cancer stages exhibited higher KAI1 and nm23-H1 immunostaining than advanced tumor stages. <\/jats:p><jats:p> CONCLUSION: Differences in the expression patterns of the two tumor suppressor genes nm23-H1 and KAI1 may contribute to the different prognoses of papilla of Vater cancer and pancreatic cancer. Our findings support the hypothesis that biologic differences rather than earlier diagnosis influence the different outcomes of these two tumor entities. <\/jats:p>","DOI":"10.1200\/jco.2001.19.9.2422","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T06:55:01Z","timestamp":1487919301000},"page":"2422-2432","source":"Crossref","is-referenced-by-count":24,"title":["Differential Expression of Metastasis-Associated Genes in Papilla of Vater and Pancreatic Cancer Correlates With Disease Stage"],"prefix":"10.1200","volume":"19","author":[{"given":"Helmut","family":"Friess","sequence":"first","affiliation":[{"name":"From the Department of Visceral and Transplantation Surgery and Institute of Pathology, University of Bern, Inselspital, Bern, Switzerland, and Division of Endocrinology, Diabetes and Metabolism, and Departments of Medicine, Biological Chemistry, and Pharmacology, University of California, Irvine, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Zhong","family":"Guo","sequence":"additional","affiliation":[{"name":"From the Department of Visceral and Transplantation Surgery and Institute of Pathology, University of Bern, Inselspital, Bern, Switzerland, and Division of Endocrinology, Diabetes and Metabolism, and Departments of Medicine, Biological Chemistry, and Pharmacology, University of California, Irvine, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrien A.","family":"Tempia-Caliera","sequence":"additional","affiliation":[{"name":"From the Department of Visceral and Transplantation Surgery and Institute of Pathology, University of Bern, Inselspital, Bern, Switzerland, and Division of Endocrinology, Diabetes and Metabolism, and Departments of Medicine, Biological Chemistry, and Pharmacology, University of California, Irvine, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Fukuda","sequence":"additional","affiliation":[{"name":"From the Department of Visceral and Transplantation Surgery and Institute of Pathology, University of Bern, Inselspital, Bern, Switzerland, and Division of Endocrinology, Diabetes and Metabolism, and Departments of Medicine, Biological Chemistry, and Pharmacology, University of California, Irvine, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus E.","family":"Martignoni","sequence":"additional","affiliation":[{"name":"From the Department of Visceral and Transplantation Surgery and Institute of Pathology, University of Bern, Inselspital, Bern, Switzerland, and Division of Endocrinology, Diabetes and Metabolism, and Departments of Medicine, Biological Chemistry, and Pharmacology, University of California, Irvine, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Zimmermann","sequence":"additional","affiliation":[{"name":"From the Department of Visceral and Transplantation Surgery and Institute of Pathology, University of Bern, Inselspital, Bern, Switzerland, and Division of Endocrinology, Diabetes and Metabolism, and Departments of Medicine, Biological Chemistry, and Pharmacology, University of California, Irvine, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murray","family":"Korc","sequence":"additional","affiliation":[{"name":"From the Department of Visceral and Transplantation Surgery and Institute of Pathology, University of Bern, Inselspital, Bern, Switzerland, and Division of Endocrinology, Diabetes and Metabolism, and Departments of Medicine, Biological Chemistry, and Pharmacology, University of California, Irvine, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus W.","family":"B\u00fcchler","sequence":"additional","affiliation":[{"name":"From the Department of Visceral and Transplantation Surgery and Institute of Pathology, University of Bern, Inselspital, Bern, Switzerland, and Division of Endocrinology, Diabetes and Metabolism, and Departments of Medicine, Biological Chemistry, and Pharmacology, University of California, Irvine, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"R1-088294","doi-asserted-by":"publisher","DOI":"10.1126\/science.7112116"},{"key":"R2-088294","unstructured":"Nicolson  GL:   Tumor cell instability, diversification, and progression to the metastatic phenotype:   From oncogene to oncofetal expression.   Cancer Res 47:  1473,1987-1487,"},{"key":"R3-088294","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6060(97)90048-9"},{"key":"R4-088294","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(98)00243-8"},{"key":"R5-088294","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199202133260706"},{"key":"R6-088294","unstructured":"Ahlgren  JD:   Epidemiology and risk factors in pancreatic cancer.   Semin Oncol 23:  241,1996-250,"},{"key":"R7-088294","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(91)80988-F"},{"key":"R8-088294","doi-asserted-by":"publisher","DOI":"10.1126\/science.7754374"},{"key":"R9-088294","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.2870040113"},{"key":"R10-088294","doi-asserted-by":"crossref","unstructured":"Steeg  PS,   Bevilacqua  G,   Pozzatti  R,  et al:  Altered expression of nm23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis.   Cancer Res 48:  6550,1988-6554,","DOI":"10.1007\/978-3-642-74236-1_7"},{"key":"R11-088294","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90404-M"},{"key":"R12-088294","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1994.442"},{"key":"R13-088294","doi-asserted-by":"publisher","DOI":"10.1007\/BF00114973"},{"key":"R14-088294","unstructured":"Guo  XY,   Friess  H,   Graber  HU,  et al:   expression is upregulated in early pancreatic cancer and decreased in the presence of metastases.   Cancer Res 56:  4876,1996-4880,   KAI1"},{"key":"R15-088294","unstructured":"Adachi  M,   Taki  T,   Ieki  Y,  et al:  Correlation of \/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.   Cancer Res 56:  1751,1996-1755,   KAI1"},{"key":"R16-088294","unstructured":"Yu  Y,   Yang  JL,   Markovic  B,  et al:  Loss of  messenger RNA expression in both high-grade and invasive human bladder cancers.   Clin Cancer Res 3:  1045,1997-1049,   KAI1"},{"key":"R17-088294","unstructured":"Lombardi  DP,   Geradts  J,   Foley  JF,  et al:  Loss of  expression in the progression of colorectal cancer.   Cancer Res 59:  5724,1999-5731,   KAI1"},{"key":"R18-088294","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6060(99)70028-0"},{"key":"R20-088294","unstructured":"Friess  H,   Yamanaka  Y,   B\u00fcchler  MW,  et al:  Enhanced expression of the type II transforming growth factor-beta receptor in human pancreatic cancer cells without alteration of type III receptor expression.   Cancer Res 53:  2704,1993-2707,"},{"key":"R21-088294","doi-asserted-by":"crossref","unstructured":"Korc  M,   Chandrasekar  B,   Yamanaka  Y,  et al:  Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increase in levels of epidermal growth factor and transforming growth factor alpha.   J Clin Invest 90:  1353,1992-1360,","DOI":"10.1172\/JCI116001"},{"key":"R22-088294","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199802000-00011"},{"key":"R23-088294","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910620409"},{"key":"R24-088294","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018814416903"},{"key":"R25-088294","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19980821)79:4<349::AID-IJC7>3.0.CO;2-V"},{"key":"R26-088294","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)91084-U"},{"key":"R27-088294","unstructured":"Friess  H,   Yamanaka  Y,   B\u00fcchler  MW,  et al:  Increased expression of acidic and basic fibroblast growth factors in chronic pancreatitis.   Am J Pathol 144:  117,1994-128,"},{"key":"R28-088294","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280606"},{"key":"R29-088294","doi-asserted-by":"publisher","DOI":"10.1159\/000172289"},{"key":"R30-088294","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199912000-00005"},{"key":"R31-088294","doi-asserted-by":"publisher","DOI":"10.1016\/S1055-3207(18)30282-5"},{"key":"R32-088294","doi-asserted-by":"publisher","DOI":"10.1007\/BF00202070"},{"key":"R33-088294","unstructured":"Rozenblum  E,   Schutte  M,   Goggins  M,  et al:  Tumor-suppressive pathways in pancreatic carcinoma.   Cancer Res 57:  1731,1997-1734,"},{"key":"R34-088294","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1999.tb09515.x"},{"key":"R35-088294","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940115)73:2<259::AID-CNCR2820730205>3.0.CO;2-V"},{"key":"R36-088294","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9098(199706)65:2<111::AID-JSO7>3.0.CO;2-A"},{"key":"R37-088294","unstructured":"Guo  XZ,   Friess  H,   Maurer  C,  et al:  KAl1 is unchanged in metastatic and nonmetastatic esophageal and gastric cancers.   Cancer Res 58:  75375,1998-75378,"},{"key":"R38-088294","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.26.14911"},{"key":"R39-088294","doi-asserted-by":"publisher","DOI":"10.1007\/BF02482235"},{"key":"R40-088294","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/84.17.1349"},{"key":"R41-088294","doi-asserted-by":"crossref","unstructured":"Shimada  M,   Taguchi  K,   Hasegawa  H,  et al:   expression in intrahepatic or extrahepatic metastases of hepatocellular carcinoma.   Liver 18:  337,1998-342,   Nm23-H1","DOI":"10.1111\/j.1600-0676.1998.tb00815.x"},{"key":"R42-088294","doi-asserted-by":"crossref","unstructured":"Nakamori  S,   Ishikawa  O,   Ohigashi  H,  et al:  Clinicopathological features and prognostic significance of nucleoside diphosphate kinase\/nm23 gene product in human pancreatic exocrine neoplasms.   Int J Pancreatol 14:  125,1993-133,","DOI":"10.1007\/BF02786118"},{"key":"R43-088294","doi-asserted-by":"publisher","DOI":"10.1007\/BF02803906"},{"key":"R44-088294","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.11.6.9194523"},{"key":"R45-088294","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201648"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2001.19.9.2422","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T21:31:09Z","timestamp":1653514269000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2001.19.9.2422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5,1]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2001,5,1]]}},"alternative-id":["10.1200\/JCO.2001.19.9.2422"],"URL":"https:\/\/doi.org\/10.1200\/jco.2001.19.9.2422","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5,1]]}}}